US 10344078
Type III secretion system targeting molecules
granted A61KA61K38/00A61P
Quick answer
US patent 10344078 (Type III secretion system targeting molecules) held by Inhibrx, Inc. expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04